Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals

Jane Robertson, Ray Moynihan, Emily Walkom, Lisa Bero and David Henry

PLOS Medicine, 2009, vol. 6, issue 11, 1-5

Abstract: David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, and argue that they fall short and instead more comprehensive reporting standards are needed.

Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000128 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 00128&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1000128

DOI: 10.1371/journal.pmed.1000128

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().